When did Veracyte report Q4 2024 earnings?

Veracyte (VCYT) reported Q4 2024 earnings on February 24, 2025 after market close.

What were Veracyte's Q4 2024 revenue and EPS?

Veracyte reported revenue of $118.6M and eps of $0.36 for Q4 2024.

Did Veracyte beat estimates in Q4 2024?

Revenue beat the consensus estimate of $110.7M by $7.9M. EPS beat the consensus estimate of $0.10 by $0.26.

Where can I find Veracyte's Q4 2024 SEC filings?

You can read the 10-K periodic report (0001384101-25-000014) directly on SEC EDGAR. The filing index links above go to sec.gov.

Veracyte VCYT Q4 2024 Annual earnings

Reported February 24, 2025 · After market close

Revenue$118.6MBeat by $7.9M

EPS$0.36Beat by $0.26

Revenue estimate$110.7M

EPS estimate$0.10

Next report

Jul 30, 2026 (Tomorrow)

Revenue estimate$144.6M

EPS estimate$0.44

Financials

Q4 2024

Income statement

See full

Revenue$118.6M+20.8%

Gross profit$78.8M+21.6%

Operating income$4.2M+112%

Net income$5.1M+118%

EPS (diluted)$0.06+116%

Balance sheet

See full

Cash & equivalents$240.6M+10.7%

Total debt$50.7M+299%

Total equity$1.2B+12.6%

Total assets$1.3B+16.6%

Cash flow

See full

Operating cash flow$24.5M+57.7%

CapEx$4.1M+65.8%

Free cash flow$20.4M+56.1%

Valuation & ratios

Valuation

as of 12/31/24

See full

Market cap$3.07B+52.6%

Enterprise value$2.88B+59.4%

P/E127.1×—

P/S6.9×+1.3×

Profitability

See full

Gross margin66.9%+3.3pp

Operating margin3.6%+1.9pp

Net margin5.4%+3.0pp

FCF margin14.3%+4.8pp

Returns & leverage

See full

Return on equity2.2%+1.2pp

Debt / equity0×0.0×

Current ratio4.7×+0.1×

Segments

By segment

See full

Reportable Segment$118.6M+31.4%

By geography

See full

United States$105.9M—

By product

See full

Testing revenue$112.2M—

Versus estimates

Revenue

Q1 2026$139.1MBeat by $8.7M Q4 2025$140.6MBeat by $4.8M Q3 2025$131.9MMiss by $3.9M Q2 2025$130.2MBeat by $5.8M Q1 2025$114.5MBeat by $3.5M

Q4 2024$118.6MBeat by $7.9M

Diluted EPS

Q1 2026$0.52Beat by $0.18 Q4 2025$0.53Beat by $0.12 Q3 2025$0.51Beat by $0.19 Q2 2025$0.44Beat by $0.13 Q1 2025$0.31Beat by $0.11

Q4 2024$0.36Beat by $0.26

Ask the moment Veracyte reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI

Claude

Questions, answered.

When did Veracyte report Q4 2024 earnings?: Veracyte (VCYT) reported Q4 2024 earnings on February 24, 2025 after market close.
What were Veracyte's Q4 2024 revenue and EPS?: Veracyte reported revenue of $118.6M and eps of $0.36 for Q4 2024.
Did Veracyte beat estimates in Q4 2024?: Revenue beat the consensus estimate of $110.7M by $7.9M. EPS beat the consensus estimate of $0.10 by $0.26.
Where can I find Veracyte's Q4 2024 SEC filings?: You can read the 10-K periodic report (0001384101-25-000014) directly on SEC EDGAR. The filing index links above go to sec.gov.